Beyond decreased ovarian reserve: considering reproductive comorbidities in female cancer survivors

Fertil Steril. 2018 Mar;109(3):446-447. doi: 10.1016/j.fertnstert.2017.12.020.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Mullerian Hormone
  • Cancer Survivors*
  • Comorbidity
  • Female
  • Humans
  • Infertility, Female
  • Neoplasms
  • Ovarian Diseases
  • Ovarian Reserve*
  • Ovary
  • Survivors

Substances

  • Anti-Mullerian Hormone